114 related articles for article (PubMed ID: 37909949)
21. Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer.
Kita R; Miyata H; Sugimura K; Tanaka K; Makino T; Yamashita K; Yamasaki M; Motoori M; Shiraishi O; Kimura Y; Yasuda T; Yano M; Doki Y
Clin Nutr; 2021 Jun; 40(6):4380-4385. PubMed ID: 33526287
[TBL] [Abstract][Full Text] [Related]
22. Impact of body fat and muscle quantity on short- and long-term outcome after gastrectomy for cancer.
Uchida T; Sekine R; Matsuo K; Kigawa G; Umemoto T; Tanaka K
Clin Nutr; 2022 Jul; 41(7):1467-1474. PubMed ID: 35662018
[TBL] [Abstract][Full Text] [Related]
23. Body mass index and skeletal muscle index are useful prognostic factors for overall survival after gastrectomy for gastric cancer: Retrospective cohort study.
Kim EY; Jun KH; Kim SY; Chin HM
Medicine (Baltimore); 2020 Nov; 99(47):e23363. PubMed ID: 33217879
[TBL] [Abstract][Full Text] [Related]
24. Impact of Skeletal Muscle Mass Reduction on Long-term Survival After Radical Resection of Gastric Cancer.
Tanaka Y; Aoyagi K; Umetani Y; Tanaka YU; Kaku H; Minami T; Isobe T; Murakami N; Fujita F; Akagi Y
Anticancer Res; 2023 Aug; 43(8):3779-3786. PubMed ID: 37500123
[TBL] [Abstract][Full Text] [Related]
25. Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy.
Cho KM; Park H; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Oncotarget; 2017 Oct; 8(45):79441-79452. PubMed ID: 29108323
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of preoperative skeletal muscle status in patients with gastric cancer after radical gastrectomy.
Hu CL; Jin XH; Yuan ZD; Xiong SW; Zhang L; Hou JN; Ao S; Wu JL; Shi HP; Ji JF; Lyv GQ
Asia Pac J Clin Nutr; 2019; 28(3):442-449. PubMed ID: 31464390
[TBL] [Abstract][Full Text] [Related]
27. Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.
Taguchi S; Akamatsu N; Nakagawa T; Gonoi W; Kanatani A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Homma Y
Clin Genitourin Cancer; 2016 Jun; 14(3):237-43. PubMed ID: 26337653
[TBL] [Abstract][Full Text] [Related]
28. No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study.
Ubachs J; Koole SN; Lahaye M; Fabris C; Bruijs L; Schagen van Leeuwen J; Schreuder HWR; Hermans RH; de Hingh IH; van der Velden J; Arts HJ; van Ham M; van Dam P; Vuylsteke P; Bastings J; Kruitwagen RFPM; Lambrechts S; Olde Damink SWM; Rensen SS; Van Gorp T; Sonke GS; van Driel WJ
Gynecol Oncol; 2020 Dec; 159(3):706-711. PubMed ID: 33019981
[TBL] [Abstract][Full Text] [Related]
29. Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse events.
Phuong A; Marquardt JP; O'Malley R; Holt SK; Laidlaw G; Eagle Z; Ngo S; Orcutt D; Schade GR; Lin DW; Schweizer MT; Yezefski T; Yu EY; Montgomery B; Grivas P; Fintelmann FJ; Psutka SP
Urol Oncol; 2022 Oct; 40(10):456.e19-456.e30. PubMed ID: 36028450
[TBL] [Abstract][Full Text] [Related]
30. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
31. The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients.
de Jong C; Chargi N; Herder GJM; van Haarlem SWA; van der Meer F; van Lindert ASR; Ten Heuvel A; Brouwer J; de Jong PA; Devriese LA; Huitema ADR; Egberts TCG; de Bree R; Deneer VHM
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1554-1564. PubMed ID: 35301821
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of the skeletal muscle index and an inflammation biomarker in patients with breast cancer who underwent postoperative adjuvant radiotherapy.
Hua X; Deng JP; Long ZQ; Zhang WW; Huang X; Wen W; Guo L; He ZY; Lin HX
Curr Probl Cancer; 2020 Apr; 44(2):100513. PubMed ID: 31732239
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.
Tang R; Deng JP; Zhang L; Zhang WW; Sun JY; Chi F; Zhang J; Wu SG; He ZY
BMC Cancer; 2022 Mar; 22(1):234. PubMed ID: 35241010
[TBL] [Abstract][Full Text] [Related]
34. Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study.
Liu J; Yu X; Huang X; Lai Q; Chen J
Cancer Imaging; 2023 Jan; 23(1):5. PubMed ID: 36635737
[TBL] [Abstract][Full Text] [Related]
35. Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study.
Cortellini A; Bozzetti F; Palumbo P; Brocco D; Di Marino P; Tinari N; De Tursi M; Agostinelli V; Patruno L; Valdesi C; Mereu M; Verna L; Lanfiuti Baldi P; Venditti O; Cannita K; Masciocchi C; Barile A; McQuade JL; Ficorella C; Porzio G
Sci Rep; 2020 Jan; 10(1):1456. PubMed ID: 31996766
[TBL] [Abstract][Full Text] [Related]
36. Prediction of Everolimus Toxicity and Prognostic Value of Skeletal Muscle Index in Patients With Metastatic Renal Cell Carcinoma.
Auclin E; Bourillon C; De Maio E; By MA; Seddik S; Fournier L; Auvray M; Dautruche A; Vano YA; Thibault C; Joly F; Brunereau L; Gomez-Roca C; Chevreau C; Elaidi R; Oudard S
Clin Genitourin Cancer; 2017 Jun; 15(3):350-355. PubMed ID: 28216276
[TBL] [Abstract][Full Text] [Related]
37. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Creemers GM; Erdkamp FLG; de Jongh FE; Kint PAM; Poppema BJ; Radema SA; Simkens LHJ; Tanis BC; Tjin-A-Ton MLR; Van Der Velden A; Punt CJA; Koopman M; May AM
Cancer Med; 2020 Feb; 9(3):1033-1043. PubMed ID: 31850687
[TBL] [Abstract][Full Text] [Related]
38. The impact of skeletal muscle abnormalities on tolerance to adjuvant chemotherapy and radiation and outcome in patients with endometrial cancer.
Ganju RG; TenNapel M; Spoozak L; Chen AM; Hoover A
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):104-112. PubMed ID: 31397078
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of low pre-transplant skeletal muscle mass on survival outcomes in patients undergoing hematopoietic stem cell transplantation.
Sakatoku K; Ito A; Tajima K; Yamaguchi K; Kuno M; Aoki N; Tanaka T; Kurosawa S; Inamoto Y; Kim SW; Fukuda T
Int J Hematol; 2020 Feb; 111(2):267-277. PubMed ID: 31713713
[TBL] [Abstract][Full Text] [Related]
40. Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib.
Uojima H; Chuma M; Tanaka Y; Hidaka H; Nakazawa T; Iwabuchi S; Kobayashi S; Hattori N; Ogushi K; Morimoto M; Kagawa T; Tanaka K; Kako M; Koizumi W
Liver Cancer; 2020 Apr; 9(2):193-206. PubMed ID: 32399433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
